Clinical Trials Logo

Brain Tumor, Recurrent clinical trials

View clinical trials related to Brain Tumor, Recurrent.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01966809 Terminated - Clinical trials for Brain Tumor, Recurrent

Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

Start date: June 2015
Phase: Phase 2
Study type: Interventional

This study will be aimed at investigating the effectiveness of a treatment for brain tumors called Photodynamic Therapy, or PDT. Briefly, a subject will receive a light-sensitive drug, called Photofrin®, the day before a tumor removal surgery. The next day, after the tumor is removed, red light from a laser will be shone into the tumor cavity through a light-diffusing sphere. This light will activate the photosensitizer, and possibly kill any tumor cells that may be left. We plan to measure how long the subject may go without a new tumor regrowth, and overall how long subjects survive. We will compare these results to typical results to see if we are seeing any improvements. Objective: To define the antitumor activity of Photofrin® and laser light activation within the confines of a Phase II study.